Getting full power over your documents at any time is essential to ease your everyday tasks and enhance your productivity. Accomplish any objective with DocHub tools for papers management and hassle-free PDF editing. Access, change and save and incorporate your workflows with other protected cloud storage services.
DocHub gives you lossless editing, the possibility to work with any formatting, and safely eSign papers without having searching for a third-party eSignature alternative. Maximum benefit of the file management solutions in one place. Try out all DocHub functions right now with the free of charge account.
The U.S. is ending the public health emergency for COVID-19, with Pfizer's CEO indicating that this will not significantly impact the company. The FDA confirmed that existing emergency use authorizations remain unaffected. Pfizer plans to transition its vaccines and antiviral drugs to a commercial market in the latter half of the year. The expected pricing for the vaccine is projected to be between $110 and $130 per dose, a rise from the initial $20, which has faced political criticism. The CEO defended the pricing as responsible and cost-effective. Pricing for the Paxlovid antiviral has not yet been disclosed. Pfizer's new CFO, Dave Denton, discussed biotech valuations and potential acquisition candidates.